Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
about
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safetySensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samplesA mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India.Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light.Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.Comparison of two algorithms to confirm and discriminate samples initially reactive for nucleic acid amplification tests.Detection and identification of occult HBV in blood donors in Taiwan using a commercial, multiplex, multi-dye nucleic acid amplification technology screening test.Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?
P2860
Q36034896-C4790DB1-626C-4BAB-B703-4EF25196EDA7Q36554189-64C923D3-FDCD-43EB-9EE8-E936D595DDBCQ37305718-43FBA0B1-2755-45D9-B4C9-DF328B0C60E1Q37333836-282023BB-8446-4122-B4B4-876AFAD7F059Q38283607-4E628196-26D7-495D-B65A-2FE83E9D1455Q38984355-81133334-2F1B-46A1-B57F-A29576EFC0BFQ39347172-EE82D0A5-9EB4-429D-A2D7-916821A22D51Q40903377-C2417467-40E8-483A-A8CF-B55003E46BC8Q41332068-8A7ABD99-E130-448D-9E00-BE0190137D56Q41647666-A5D91CF5-A457-4972-A448-3160F18DD28DQ42142990-9C7516C8-F630-4698-8A56-2D1C241FE405Q42279560-027BD2A4-1FCA-4B66-B1E2-184A9CFE9477Q51743195-FC8AA4D8-4542-4E10-8FC5-CEF391E93331
P2860
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Head-to-head comparison of two ...... virus Type 1 in blood donors.
@en
Head-to-head comparison of two ...... virus Type 1 in blood donors.
@nl
type
label
Head-to-head comparison of two ...... virus Type 1 in blood donors.
@en
Head-to-head comparison of two ...... virus Type 1 in blood donors.
@nl
prefLabel
Head-to-head comparison of two ...... virus Type 1 in blood donors.
@en
Head-to-head comparison of two ...... virus Type 1 in blood donors.
@nl
P2093
P2860
P50
P356
P1433
P1476
Head-to-head comparison of two ...... y virus Type 1 in blood donors
@en
P2093
Daniel Candotti
Dariusz Piotrowski
Grzegorz Liszewski
Harry van Drimmelen
Joanna Górska
Jolanta Gdowska
Jolanta Kuśmierczyk
Magdalena Lętowska
Nico Lelie
P2860
P304
P356
10.1111/TRF.12190
P433
P577
2013-04-17T00:00:00Z